CUSIP: 74374N102
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,271,540
-
Share change
-
+1,400,205
-
Total reported value
-
$285,747,357
-
Put/Call ratio
-
32%
-
Price per share
-
$12.83
-
Number of holders
-
100
-
Value change
-
+$16,894,756
-
Number of buys
-
54
-
Number of sells
-
42
Quarterly Holders Quick Answers
What is CUSIP 74374N102?
CUSIP 74374N102 identifies PRVB - PROVENTION BIO INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2020
-
Previous quarter:
Q2 2020
Recent filing periods for CUSIP 74374N102:
Institutional Holders of PROVENTION BIO INC - COM (PRVB) as of Q3 2020
As of 30 Sep 2020,
PROVENTION BIO INC - COM (PRVB) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,271,540 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, GILDER GAGNON HOWE & CO LLC, STATE STREET CORP, 683 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Johnson & Johnson Innovation - JJDC, Inc., and TWO SIGMA ADVISERS, LP.
This page lists
100
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.